from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2033c/-

LFCtreatmentdescriptionclass of inhibitor

-0.123

Amikacinug/mL Amikacintranslation

0.484

Cap5-10ug/mL Capreomycintranslation

-0.074

Rox10-50 ug/mL Roxithromycintranslation

-0.639

SM2-5 ug/mL Streptomycintranslation

-0.690

Tet5-10 ug/mL Tetracyclinetranslation

-0.512

Rif0.2-5ug/mL Rifampicintranscription

0.861

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.756

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.170

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.198

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.179

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.010

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.425

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.297

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.572

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.024

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.542

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.091

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.485

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.684

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.002

KCN5-20 ug/mL Potassium cyaniderespiration

-0.462

NaN30.2-2 mM Sodium aziderespiration

0.252

Nigericin50 uM Nigericinrespiration

0.227

TRC10-150 ug/mL Triclosanrespiration

-0.695

TRZ10-25 ug/mL Thioridazinerespiration

-1.193

Valinomycin0.5-10 uM Valinomycinrespiration

1.400

ZnSO42 mM ZnSO4respiration

-1.155

menadione6-10 ug/mL Menadionerespiration

-0.610

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.887

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.026

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.862

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.556

NRP_1Non-replicating persistence stage 1dosRassociated

1.174

Amp0.2mg/mL AmpicillincellWall

1.255

Cephalexin20-100 ug/mL CephalexincellWall

-0.015

Cerulenin0.32-5 ug/mL CerulenincellWall

0.765

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.191

EMB10-20 ug/mL EthambutolcellWall

0.081

Eta12-40 ug/mL EthionamidecellWall

0.580

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.439

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.326

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.546

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.463

BZA0.12 mg/mL BenzamidearomaticAmides

0.200

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.518

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.228

H2O24 mM hydrogen peroxideDNAdamaging

0.422

Levo10 ug/mL LevofloxacinDNAdamaging

0.349

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.864

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.393

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.026

UVUV-irradiationDNAdamaging

-1.617

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.174

Antimycin12.5-50 ug/mL Antimycin A?

0.885

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.147

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.006

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.277

PA8240.2-2 ug/mL PA-824?

0.458

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.367

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

0.294

mercaptoethanol2 mM 2-Mercaptoethanol?

0.860

methoxatin10-20 ug/mL Methoxatin?